Full Text View
Tabular View
No Study Results Posted
Related Studies
Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies
This study has been completed.
Study NCT00001261   Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999   Last Updated: March 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Dermatomyositis
Inclusion Body Myositis
Polymyositis
Additional conditions recognized in this trial
Myositis
Myositis, Inclusion Body
More general conditions related to this trial
Connective Tissue Diseases
Muscular Diseases
Musculoskeletal Diseases
Nervous System Diseases
Neuromuscular Diseases
Skin Diseases
Interventions listed in this trial
Gamma Globulin
Additional drug interventions recognized in this trial
Gamma-Globulins
Immunoglobulins
Immunoglobulins, Intravenous
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Institute of Neurological Disorders and Stroke (NINDS)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services